Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2049163
Max Phase: Preclinical
Molecular Formula: C30H62N20O6
Molecular Weight: 798.96
Molecule Type: Protein
Associated Items:
ID: ALA2049163
Max Phase: Preclinical
Molecular Formula: C30H62N20O6
Molecular Weight: 798.96
Molecule Type: Protein
Associated Items:
Canonical SMILES: N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)O
Standard InChI: InChI=1S/C30H62N20O6/c31-16(6-1-11-42-26(32)33)21(51)47-17(7-2-12-43-27(34)35)22(52)48-18(8-3-13-44-28(36)37)23(53)49-19(9-4-14-45-29(38)39)24(54)50-20(25(55)56)10-5-15-46-30(40)41/h16-20H,1-15,31H2,(H,47,51)(H,48,52)(H,49,53)(H,50,54)(H,55,56)(H4,32,33,42)(H4,34,35,43)(H4,36,37,44)(H4,38,39,45)(H4,40,41,46)/t16-,17-,18-,19-,20-/m0/s1
Standard InChI Key: RMSDLIVVDARAQX-HVTWWXFQSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Protein | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 798.96 | Molecular Weight (Monoisotopic): 798.5161 | AlogP: -6.35 | #Rotatable Bonds: 29 |
Polar Surface Area: 489.22 | Molecular Species: ZWITTERION | HBA: 11 | HBD: 21 |
#RO5 Violations: 3 | HBA (Lipinski): 26 | HBD (Lipinski): 27 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.97 | CX Basic pKa: 12.07 | CX LogP: -9.43 | CX LogD: -19.07 |
Aromatic Rings: 0 | Heavy Atoms: 56 | QED Weighted: 0.02 | Np Likeness Score: 0.20 |
1. López-Vallejo F, Martínez-Mayorga K.. (2012) Furin inhibitors: importance of the positive formal charge and beyond., 20 (14): [PMID:22682919] [10.1016/j.bmc.2012.05.029] |
2. Na H, Li X, Zou C, Wang C, Wang C, Liu K.. (2016) Triterpene sapogenin-polyarginine conjugates exhibit promising antibacterial activity against Gram-positive strains., 24 (13): [PMID:27209170] [10.1016/j.bmc.2016.05.008] |
Source(1):